In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Luis Parada in his lab
In the Lab
Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key

In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors.
Memorial Sloan Kettering physician-scientist Michel Sadelain.
Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy

A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
Separate headshots of three researchers — Diana Mandelker, Jorge Reis-Filho, and Fresia Pareja
Feature
How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.
Young girl
New Research Shows the HPV Cancer Vaccine Saves Lives

Learn why MSK recommends that children be vaccinated against HPV.
Archival photo of Maria Jasin and Mary Ellen Moynahan
From Breaks to Breakthroughs

Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work.
Computational biologist Quaid Morris
Looking for Patterns in Cancer Survivors

Cancer treatment is complex. For every type of cancer, there is a range of treatments, side effects, and outcomes. Machine learning can help make sense of these variables, according to Quaid Morris.
Memorial Sloan Kettering physician-scientist Vinod Balachandran.
Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic

MSK researchers are making important inroads in understanding and treating pancreatic cancer.
SKI scientists David Scheinberg and Derek Tan
Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs

These souped-up versions may help overcome some limitations of existing CAR T cells.
Valerie Rusch, Murray Brennan, Bob Li, Charles Rudin
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discuss Opportunities for Further Collaboration to Accelerate International Clinical Trials During Annual Symposium

Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK)...
African-American surgeon in scrubs and mask leaning over patient in OR.
2021 in Review: 10 Important Clinical Advances in Cancer at MSK

Learn about some of the most important clinical advances made at MSK in 2021.